Management of Exanthematous Rashes
The management of exanthematous rashes should focus on identifying the underlying cause, treating inflammation, addressing potential infections, and maintaining skin barrier function through appropriate topical treatments and systemic therapies when indicated.
Diagnosis and Assessment
- Exanthematous rashes present with various morphologies including papulopustular, maculopapular, erythematous, or vesiculobullous patterns, requiring careful assessment to determine etiology 1
- Potential causes include viral infections, drug reactions, bacterial infections, immune checkpoint inhibitor therapy, and anticancer agents 1, 2
- Evaluate for systemic symptoms such as fever, mucosal involvement, organ dysfunction, or eosinophilia which may indicate severe drug reactions 2
- Assess distribution and morphology of the rash, as these characteristics help differentiate between infectious, allergic, or drug-induced causes 3
- Consider timing of rash in relation to medication exposure, which is critical for identifying drug-induced exanthems 2, 4
Management Approach Based on Etiology
Drug-Induced Exanthematous Rashes
For anticancer agent-induced rashes (e.g., EGFR inhibitor-related):
- Avoid frequent washing with hot water and skin irritants such as OTC anti-acne medications 5
- Apply alcohol-free moisturizers containing 5-10% urea twice daily 5
- For grade 1-2 rashes, use topical corticosteroids and oral tetracycline antibiotics (doxycycline 100mg twice daily or minocycline 100mg daily) for at least 6 weeks 5
- For grade 3 rashes, consider short-course systemic corticosteroids (prednisone 0.5-1 mg/kg for 7 days with 4-6 week taper) and interrupt the causative medication until rash improves to grade 1 5
For immune checkpoint inhibitor-related rashes:
- Grade 1 (rash <10% BSA): Continue immunotherapy while treating with topical emollients and mild-moderate potency corticosteroids 5
- Grade 2 (rash 10-30% BSA): Consider holding immunotherapy, use medium-high potency topical corticosteroids, oral antihistamines, and possibly prednisone 0.5-1 mg/kg 5
- Grade 3-4 (rash >30% BSA or life-threatening): Hold immunotherapy, initiate systemic corticosteroids (prednisone 1 mg/kg/day or IV methylprednisolone 1-2 mg/kg), and consult dermatology 5
Infectious Exanthematous Rashes
For suspected bacterial superinfection (indicated by painful lesions, yellow crusts, or discharge):
- Obtain bacterial culture and administer appropriate antibiotics for at least 14 days based on sensitivity results 5
- For Staphylococcus aureus (most common pathogen), consider flucloxacillin 5
- For β-hemolytic streptococci, use phenoxymethylpenicillin 5
- For patients with penicillin allergy, erythromycin is an appropriate alternative 5
For viral exanthems:
- Treatment is generally supportive as most viral exanthems are self-limiting 6
- For herpes virus infections presenting with mucosal involvement (eczema herpeticum), administer oral acyclovir early in the disease course or intravenous acyclovir for ill, febrile patients 5
- Avoid unnecessary antibiotics which may be mistakenly prescribed due to confusion between viral exanthems and drug eruptions 4
General Skin Care Recommendations
- Use gentle, non-irritating cleansers and avoid frequent washing with hot water 5
- Apply alcohol-free moisturizers regularly to maintain skin barrier function 5
- Use sun protection (SPF 15 or higher) on exposed areas of the body 5
- Avoid skin irritants including harsh soaps, solvents, and disinfectants 5
- Wear loose-fitting, breathable clothing to reduce friction and occlusion 7
When to Refer to Dermatology
- Rashes that do not respond to first-line treatment measures 5
- Suspected autoimmune skin disease 5
- Severe rashes (grade 3-4) or those with systemic symptoms 5, 2
- Cases requiring skin biopsy for definitive diagnosis 5, 2
- Suspected severe cutaneous adverse reactions (SCARs) such as Stevens-Johnson syndrome/toxic epidermal necrolysis 2
Red Flags Requiring Urgent Intervention
- Mucosal involvement (oral, ocular, genital) suggesting Stevens-Johnson syndrome/toxic epidermal necrolysis 2
- Fever, malaise, and organ dysfunction suggesting drug reaction with eosinophilia and systemic symptoms (DRESS) 2
- Petechial or purpuric rash which may indicate meningococcemia or other serious conditions 3
- Rapidly progressing rash with systemic symptoms 3
- Blistering or skin sloughing 2